In a phase 3 trial, the agent reduces seizure frequency by up to 53% in treatment-resistant focal epilepsy, with rapid onset ...

Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study ...

The study sought to evaluate the efficacy, safety, and tolerability of azetukalner, administered as an oral, adjunctive, once ...

Please provide your email address to receive an email when new articles are posted on . No serious device- or implant-related adverse events were reported. A high degree of seizures and related ...

MUNCIE, Ind. – Seizures are a common brain disease that likely everyone will experience or witness within their lifetime. Some can last a few seconds and aren’t life threatening while others can be ...

Poststroke epilepsy is linked to a significantly higher risk for dementia, suggesting a need for increased surveillance and ...

Seizures tend to get progressively worse over time in people with epilepsy, and a new study in mice suggests why that might be the case. Seizures appear to prompt the brains of mice to produce more ...

For people with epilepsy, getting poor sleep was associated with a higher risk of dementia compared to people without ...